The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting signs and symptoms of the condition.

U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

The Food and Drug Administration (FDA) has cleared Lumipulse G for U.S. commercialization as the first blood-based test that ...

In this environment, diagnostics and testing appear comparatively safer, and companies like GeneDx and Natera, Inc. (NTRA), another Prudent Healthcare model portfolio holding, appear to be better ...

US & Canada, April 28, 2025 (GLOBE NEWSWIRE) -- As per a new, comprehensive report from The Insight Partners, the Point of Care Diagnostics Market is experiencing significant growth owing to ...

"With advances in experimental diagnostics, technology and computing, we are now at a point where we can understand it because we have these new tools," Khare said. But there is still much to explore.

Inc., 4 in partnership with Fujirebio, Inc., a developer of clinical diagnostics in Japan, 4 and Heidelberg University Hospital in Germany. This project will leverage Fluxus' cutting-edge ...

A groundbreaking microscope at Harvard Medical School could lead to breakthroughs in cancer detection and research into longevity. But the scientist who developed computer scripts to read its ...

Quest Diagnostics reported its Q1 2025 earnings, surpassing market expectations with an adjusted earnings per share (EPS) of $2.21, compared to a forecasted $2.16. Revenue reached 2.65 billion ...

These investments further strengthen Roche’s already significant US footprint with 13 manufacturing and 15 R&D sites across the Pharmaceutical and Diagnostics Divisions, and are expected to ...